Higashiosaka, Japan

Katsuhiro Ibata


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katsuhiro Ibata: Innovator in Anti-Ulcer Compounds

Introduction

Katsuhiro Ibata is a notable inventor based in Higashiosaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that are useful in treating ulcers. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Katsuhiro Ibata holds a patent for pyridinyl acetamide compounds that are effective in treating ulcers. The patent describes acetamide compounds represented by a specific formula, where various groups can be represented by hydrogen atoms, alkyl or alkenyl groups, cycloalkyl or cycloalkenyl groups, and aromatic groups. These compounds exhibit potent anti-ulcer activity and are beneficial for treating ulcers in mammals. He has 1 patent to his name, reflecting his innovative contributions to medical science.

Career Highlights

Katsuhiro Ibata is associated with Hamari Chemicals, Ltd., where he continues to work on developing pharmaceutical solutions. His career is marked by a commitment to research and innovation, particularly in the area of medicinal chemistry. His work has the potential to impact the treatment of ulcer-related conditions significantly.

Collaborations

Katsuhiro has collaborated with notable colleagues such as Naomichi Mitsumori and Yasuhiro Nishimura. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Katsuhiro Ibata is a distinguished inventor whose work in developing anti-ulcer compounds has made a significant impact in the pharmaceutical industry. His dedication to innovation and collaboration continues to drive advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…